MetaCap

Who Owns Aclaris Therapeutics Stock?

NASDAQ: ACRSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.44-0.06 (-1.71%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
87.30%
Institutional holders
217
  • Institutions 87.3%
  • Insiders 2.0%
  • Public and other 10.7%

Who owns Aclaris Therapeutics stock?

Institutional investors own about 87.3% of Aclaris Therapeutics's shares, spread across 217 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 2.03% of ACRS.

The largest institutional holders are RA Capital Management, L.P. (8.02%), BML Capital Management, LLC (6.91%) and Blackrock Inc. (6.54%). Together, the top 10 institutions control 51.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ACRS positions and 1 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of ACRS

Aclaris Therapeutics top institutional holders
InstitutionShares% HeldChange
RA Capital Management, L.P.12.72M8.02%0.0%
BML Capital Management, LLC10.96M6.91%-8.5%
Blackrock Inc.10.38M6.54%+3.4%
Deep Track Capital, Lp9.35M5.89%0.0%
Frazier Life Sciences Management, L.P. 8.73M5.50%+77.2%
FMR, LLC7.05M4.44%+2145.7%
Vivo Capital, LLC6.69M4.22%0.0%
Vanguard Capital Management LLC5.86M3.70%+0.8%
MPM Bioimpact LLC5.18M3.26%+396.7%
Decheng Capital LLC4.04M2.55%0.0%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of ACRS

Aclaris Therapeutics top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund4.24M2.68%
iShares Trust-iShares Russell 2000 ETF3.09M1.95%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund1.93M1.22%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.45M0.91%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.30M0.82%
SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF1.14M0.72%
iShares Trust-iShares Russell 2000 Growth ETF969.37K0.61%
iShares Trust-iShares Biotechnology ETF878.49K0.55%
Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF834.44K0.53%
Fidelity Select Portfolios-Select Biotechnology Portfolio826.70K0.52%

Frequently asked questions

Who is the largest shareholder of Aclaris Therapeutics?

RA Capital Management, L.P. is the largest institutional shareholder of ACRS, owning 8.02% of shares outstanding (12.72M shares) as of its latest 13F filing.

What percentage of Aclaris Therapeutics is owned by institutions?

Institutions own about 87.3% of ACRS shares and 89.1% of the public float.

How much of Aclaris Therapeutics do insiders own?

Insiders, such as officers and directors, own about 2.03% of ACRS shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related